The present invention relates to amorphous adducts of ticagrelor with divalentmetal saltsuseful in the treatment or prevention of arterial thrombotic complications inpatients withcoronary artery, cerebrovascular or peripheral vascular disease. In anembodiment, describedherein is an adduct of a compound of formula I with a divalent metal salt:(see formula I).
